A Study to Evaluate the Safety and Effectiveness of the FastWave Artero™ Peripheral Intravascular Lithotripsy (IVL) System in Adults With Peripheral Artery Disease (PAD)

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFastWave Medical

About this trial

The purpose of this clinical study is to learn if the FastWave Artero™ Peripheral Intravascular Lithotripsy (IVL) System is safe and works well to help people with peripheral artery disease (PAD) who have hard, calcium-filled blockages in their leg arteries.

The study will test the idea that using sound waves inside the artery can safely break up calcium and make it easier to open the artery so blood can flow better.

The main question this study is trying to answer is:

Can treatment with the FastWave Artero™ IVL System safely widen blocked leg arteries and lower the chance of serious problems during or after the procedure?

About 110 adults at up to 30 medical centers in the United States will take part. Everyone in the study will receive the IVL treatment.

During the study, participants will:

Have a minimally invasive procedure using the FastWave IVL System

Stay for a short observation period after the procedure

Return for follow-up visits about 30 days and 6 months later

Researchers will look at how well the arteries open, how long they stay open, and whether any major complications occur. The results will help determine if the FastWave Artero™ IVL System can be used as a safe and effective treatment for people with PAD and severe calcium buildup in the leg arteries.

Eligibility criteria

Qualifiers

Subject is able and willing to comply with all assessments in the study.

Subject or subject's legal representative has been informed of the nature of the study, agrees to participate, and has signed the approved consent form.

Subject is ≥ 18 years of age.

Rutherford Clinical Category 2, 3 or 4

Disqualifiers

Planned use of atherectomy, scoring or cutting balloons, or any investigational device other than lithotripsy.

Rutherford Clinical Categories 0, 1, 5, and 6.

The investigator determined no or mild calcium in the target lesion.

Subject has outflow disease in which no tibial vessel has <50% stenosis. Staged or concomitant intervention to the tibial vessels is not allowed.

Trial design

Treatments tested in this trial

  • FastWave Artero™ Peripheral IVL System

Treatment groups

110 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

FastWave Medical

Lead sponsor

Rede Optimus Hospitalar SA

Collaborator

Medical Metrics Diagnostics, Inc

Collaborator